These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 18251668)

  • 21. Clinical findings, diagnostic approach, and outcome of Brucella melitensis epididymo-orchitis.
    Colmenero JD; Muñoz-Roca NL; Bermudez P; Plata A; Villalobos A; Reguera JM
    Diagn Microbiol Infect Dis; 2007 Apr; 57(4):367-72. PubMed ID: 17141451
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Childhood brucellosis: a study of 102 cases.
    al-Eissa YA; Kambal AM; al-Nasser MN; al-Habib SA; al-Fawaz IM; al-Zamil FA
    Pediatr Infect Dis J; 1990 Feb; 9(2):74-9. PubMed ID: 2314956
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antimicrobial susceptibilities of Brucella isolates from various clinical specimens.
    Bayram Y; Korkoca H; Aypak C; Parlak M; Cikman A; Kilic S; Berktas M
    Int J Med Sci; 2011 Mar; 8(3):198-202. PubMed ID: 21448305
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative trial of rifampin-doxycycline versus tetracycline-streptomycin in the therapy of human brucellosis.
    Ariza J; Gudiol F; Pallarés R; Rufí G; Fernández-Viladrich P
    Antimicrob Agents Chemother; 1985 Oct; 28(4):548-51. PubMed ID: 4073878
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Brucella endocarditis - a registry study.
    Cay S; Cagirci G; Maden O; Balbay Y; Aydogdu S
    Kardiol Pol; 2009 Mar; 67(3):274-80. PubMed ID: 19378233
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Can brucella endocarditis be treated successfully with medical therapy alone?
    Mohandas N; Balasubramanian R; Prasad SB
    Trop Doct; 2009 Apr; 39(2):123-4. PubMed ID: 19299306
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The treatment of brucellosis using rifampicine (author's transl)].
    Bertrand A; Roux J; Janbon F; Jourdan J; Jonquet O
    Nouv Presse Med; 1979 Nov; 8(44):3635-9. PubMed ID: 534216
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Future trends in human brucellosis treatment.
    Pappas G; Papadimitriou P; Christou L; Akritidis N
    Expert Opin Investig Drugs; 2006 Oct; 15(10):1141-9. PubMed ID: 16989591
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro antibacterial activity of tigecycline in comparison with doxycycline, ciprofloxacin and rifampicin against Brucella spp.
    Turan H; Arslan H; Azap OK; Serefhanoğlu K; Uncu H
    Int J Antimicrob Agents; 2007 Aug; 30(2):186-7. PubMed ID: 17462865
    [No Abstract]   [Full Text] [Related]  

  • 30. Comparison of two durations of triple-drug therapy in patients with uncomplicated brucellosis: A randomized controlled trial.
    Sofian M; Velayati AA; Aghakhani A; McFarland W; Farazi AA; Banifazl M; Eslamifar A; Ramezani A
    Scand J Infect Dis; 2014 Aug; 46(8):573-7. PubMed ID: 24934986
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of brucellosis by PCR and persistence after treatment in patients returning to the hospital for follow-up.
    Maas KS; Méndez M; Zavaleta M; Manrique J; Franco MP; Mulder M; Bonifacio N; Castañeda ML; Chacaltana J; Yagui E; Gilman RH; Guillen A; Blazes DL; Espinosa B; Hall E; Abdoel TH; Smits HL
    Am J Trop Med Hyg; 2007 Apr; 76(4):698-702. PubMed ID: 17426173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Therapy of brucellosis: clinical experience with a rifampicin- doxycycline combination].
    Montanari M; Gandini T; Torre D; Dietz A
    Minerva Med; 1985 Jul; 76(30-31):1407-10. PubMed ID: 4022432
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Treatment of acute brucellosis with cotrimoxazole, doxicyclin and streptomycin. A comparative study (author's transl)].
    Vargas V; Pedreira JD; Clotet B; Juste C; Guardia J; Bacardi R
    Med Clin (Barc); 1980 Dec; 75(10):418-20. PubMed ID: 7007755
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Brucellosis: a retrospective evaluation of 99 cases and review of brucellosis treatment.
    Demirtürk N; Demirdal T; Erben N; Demir S; Asci Z; Kilit TP; Kartal ED
    Trop Doct; 2008 Jan; 38(1):59-62. PubMed ID: 18302876
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modern chemotherapy for brucellosis in humans.
    Hall WH
    Rev Infect Dis; 1990; 12(6):1060-99. PubMed ID: 2267485
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Administration of a triple versus a standard double antimicrobial regimen for human brucellosis more efficiently eliminates bacterial DNA load.
    Vrioni G; Bourdakis A; Pappas G; Pitiriga V; Mavrouli M; Pournaras S; Tsakris A
    Antimicrob Agents Chemother; 2014 Dec; 58(12):7541-4. PubMed ID: 25246401
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relevance of in vitro antimicrobial susceptibility of Brucella melitensis to relapse rate in human brucellosis.
    Ariza J; Bosch J; Gudiol F; Liñares J; Viladrich PF; Martín R
    Antimicrob Agents Chemother; 1986 Dec; 30(6):958-60. PubMed ID: 3813520
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Treatment of human brucellosis with rifampicin].
    Godeau P; Fuchs G; Guillevin L; Philippon A; Tucat G; Cabane J; Herson S
    Sem Hop; 1984 Jan; 60(1):5-9. PubMed ID: 6320435
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Brucellosis in children of Dhofar Region, Oman.
    El-Amin EO; George L; Kutty NK; Sharma PP; Choithramani RS; Jhaveri VP; Salil P; Bedair SM
    Saudi Med J; 2001 Jul; 22(7):610-5. PubMed ID: 11479644
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Perspectives for the treatment of brucellosis in the 21st century: the Ioannina recommendations.
    Ariza J; Bosilkovski M; Cascio A; Colmenero JD; Corbel MJ; Falagas ME; Memish ZA; Roushan MR; Rubinstein E; Sipsas NV; Solera J; Young EJ; Pappas G; ;
    PLoS Med; 2007 Dec; 4(12):e317. PubMed ID: 18162038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.